pills-384846_960_720-300x200-4567758timely study by researchers at the New York State Department of Health, just published in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, documents how widespread the use of prescription opioids has become in recent decades.

Focusing on the state’s female Medicaid recipients of reproductive age (15 to 44), the study found that fully 20 percent had been prescribed opioids at least once between 2008 and 2013.

That figure included 9.5 percent of the women who gave birth the same year, which is a particular concern because opioid use during pregnancy can cause birth defects and other health problems for newborns.

The authors–Brian Gallagher, Yejee Shin and Patrick Roohan of the Health Department’s Office of Quality and Patient Safety–noted previous studies involving other states had found even higher rates. They suggest that New York regulations, including the four-year-old Internet System for Tracking Overprescribing (I-STOP), “might contribute to the lower proportion of opioid prescribing in New York compared with opioid prescribing in most other states and the United States overall.”

The CDC reported in January that 47,055 Americans died of an opioid overdose in 2014, up 137 percent since 2000.

The rising death toll from heroin and prescription opioid overdose prompted Governor Andrew Cuomo on Tuesday to appoint a 23-member task force to combat what he called a “national epidemic.” It was the latest in a series of steps by state government to confront opioid abuse, with more likely to come.

In an op-ed Wednesday, CNN medical correspondent Dr. Sanjay Gupta argued that most of the blame for the public health crisis nationwide lies with doctors who prescribe opioids too readily and fail to properly monitor how patients use them.

As Gupta wrote, “There is no other medication routinely used for a nonfatal condition that kills patients so frequently.”

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More